The present study aimed to characterize two undescribed DNMT3A mutations identified by next-generation sequencing (NGS) in two different AML patients, through analysis of protein stability and DNA methylation status at CpG islands. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.